398 related articles for article (PubMed ID: 24807339)
1. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
Dickinson JE; Jennings BG; Doherty DA
Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.
Tang OS; Chan CC; Ng EH; Lee SW; Ho PC
Hum Reprod; 2003 Nov; 18(11):2315-8. PubMed ID: 14585880
[TBL] [Abstract][Full Text] [Related]
5. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
Tang OS; Chan CC; Kan AS; Ho PC
Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.
Ashok PW; Templeton A
Br J Obstet Gynaecol; 1999 Jul; 106(7):706-10. PubMed ID: 10428528
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
Ngai SW; Tang OS; Ho PC
Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
Tang OS; Lau WN; Chan CC; Ho PC
BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation.
Hamoda H; Ashok PW; Dow J; Flett GM; Templeton A
Contraception; 2003 Nov; 68(5):335-8. PubMed ID: 14636936
[TBL] [Abstract][Full Text] [Related]
12. Use of mifepristone and sublingual misoprostol for early medical abortion.
Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
[TBL] [Abstract][Full Text] [Related]
13. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
14. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Goh SE; Thong KJ
Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sequential vaginal and sublingual misoprostol after a vaginal loading dose for second-trimester abortion.
Huang MC; Hsieh CH; Huang JP; Tsai HT; Lee MS
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):312-314. PubMed ID: 28600039
[TBL] [Abstract][Full Text] [Related]
16. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
[TBL] [Abstract][Full Text] [Related]
17. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
Tang OS; Xu J; Cheng L; Lee SW; Ho PC
Hum Reprod; 2002 Jul; 17(7):1738-40. PubMed ID: 12093832
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.
Schaff EA; Fielding SL; Westhoff C
Contraception; 2001 Aug; 64(2):81-5. PubMed ID: 11704083
[TBL] [Abstract][Full Text] [Related]
20. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
Ho PC; Ngai SW; Liu KL; Wong GC; Lee SW
Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
